Literature DB >> 16952589

Gallbladder wall inflammatory cells in pediatric patients with biliary dyskinesia and cholelithiasis: a pilot study.

Brian Rau1, Craig A Friesen, James F Daniel, Adnan Qadeer, Ding You-Li, Charles C Roberts, George W Holcomb.   

Abstract

BACKGROUND/
PURPOSE: Inflammation has been implicated in functional gastrointestinal disorders, including functional dyspepsia and irritable bowel syndrome. This study was undertaken to evaluate gallbladder wall inflammatory cells in children with abdominal pain related to gallstones and biliary dyskinesia to determine the candidate cell types that may be contributing to the pathophysiology of these entities.
METHODS: Gallbladder specimens from 20 patients with cholelithiasis, 20 biliary patients with dyskinesia, and 12 autopsy controls were evaluated in a blinded fashion. Eosinophil, tryptase-positive, and CD3+ cell densities were determined for the lamina propria and muscularis mucosa layers and compared between groups.
RESULTS: Patients with biliary dyskinesia and cholelithiasis had a 9- to 12-fold increase in mean and peak mast cell densities, respectively, in both layers as compared with controls. Peak (13.7 vs 8.4) and mean (9.2 vs 5.2) CD3+ cell densities were increased in the muscularis mucosae of cholelithiasis specimens as compared with biliary dyskinesia specimens.
CONCLUSION: Gallbladder wall inflammatory cell densities, particularly mast cells, differ between children with cholelithiasis, children with biliary dyskinesia, and controls. Future studies are warranted to define the roles for specific inflammatory cell types.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952589     DOI: 10.1016/j.jpedsurg.2006.05.015

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Biliary hyperkinesia in adolescents-it isn't all hype!

Authors:  Maggie E Bosley; Jillian Jacobson; Michaela W G Gaffley; Michael A Beckwith; Samir R Pandya; James S Davis; Lucas P Neff
Journal:  Transl Gastroenterol Hepatol       Date:  2021-07-25

2.  Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia.

Authors:  Craig A Friesen; Nancy Neilan; James F Daniel; Kim Radford; Jennifer V Schurman; Ding-You Li; Linda Andre; Shawn D St Peter; George W Holcomb
Journal:  BMC Res Notes       Date:  2011-09-06

Review 3.  Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma.

Authors:  Marisol I González; Danielle T Vannan; Bertus Eksteen; Irán Flores-Sotelo; José Luis Reyes
Journal:  Cells       Date:  2022-01-22       Impact factor: 6.600

Review 4.  Biliary Dyskinesia in Children and Adolescents: A Mini Review.

Authors:  David A Simon; Craig A Friesen; Jennifer V Schurman; Jennifer M Colombo
Journal:  Front Pediatr       Date:  2020-03-24       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.